Skip to Content

GS UHL (Votrient pazopanib 400 mg)

Generic Name: pazopanib

Pill imprint GS UHL has been identified as Votrient pazopanib 400 mg.

Votrient is used in the treatment of soft tissue sarcoma; renal cell carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Votrient
Generic Name:
pazopanib
Imprint:
GS UHL
Strength:
pazopanib 400 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
GlaxoSmithKline

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide